Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Optical modulation element
Charging current control method and charging system
Multistable electromagnetic actuators
Portable stand
Managing method and apparatus for servicing contents provided by content provider
Intelligent and automated code deployment
Compositions of PD-1 antagonists and methods of use
  Randomly Featured Patents
Signal level conversion circuit for increasing dynamic range of analog-to-digital converter
Injection nozzle and method for injection molding
Method for processing solid material for disposal in an underground porous formation
Lever-type connector
Toughened thermoset laminates
Electronic mail communication system and method
Sulfonamide compounds
Sun deck of a personal watercraft
Alignment gage for dish antenna
Wire canister for a robotic wire harness assembly system